Quantitative Investment Management’s Celldex Therapeutics CLDX Stock Holding History

Quantitative Investment Management’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3,620	Closed	-$238K	–	690
2016 Q2	$238K	Sell	3,620 -13,293	-79%	-$844K	0.01%	656
2016 Q1	$958K	Buy	+16,913	New	+$1.9M	0.05%	405
2015 Q3	–	Sell	-573	Closed	-$216K	–	693
2015 Q2	$216K	Sell	573 -1,294	-69%	-$514K	0.03%	370
2015 Q1	$780K	Buy	+1,867	New	+$668K	0.07%	245
2014 Q2	–	Sell	-1,433	Closed	-$379K	–	482
2014 Q1	$379K	Buy	+1,433	New	+$549K	0.02%	392

Other funds holding CLDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Quantitative Investment Management's CLDX Position: Q3 2016 in Review

Quantitative Investment Management sold out of Celldex Therapeutics (CLDX) in Q3 2016, closing a stake of 3,620 shares — an estimated $238K sold.

Quantitative Investment Management first reported a position in CLDX in Q1 2014 and held it in 5 quarters. The position peaked at $958K in Q1 2016. 139 funds tracked by Wall St. Rank hold CLDX as of Q3 2016.

Quantitative Investment Management reported no remaining Celldex Therapeutics position as of Q3 2016 after selling out during the quarter.
Quantitative Investment Management sold 3,620 Celldex Therapeutics shares in Q3 2016, an estimated $238K.
Quantitative Investment Management first reported a position in Celldex Therapeutics in Q1 2014 and held it in 5 quarters.
Quantitative Investment Management's Celldex Therapeutics position peaked at $958K in Q1 2016.
139 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2016.

Based on Quantitative Investment Management's 13F filing for Q3 2016, filed 1 Nov 2016.